A common constipation drug shows surprising power to protect kidneys
2 Articles
2 Articles
A common constipation drug shows surprising power to protect kidneys
A common constipation drug may have unexpectedly unlocked a new way to slow chronic kidney disease — a condition that affects millions and often leads to dialysis. In a clinical trial involving 150 patients, researchers found that lubiprostone, a medication normally used to treat constipation, helped preserve kidney function in people with moderate CKD. Scientists traced the effect to changes in gut bacteria that boosted production of spermidine…
A recent study conducted by researchers at Tohoku University revealed that lubiprostone, a medication commonly used to treat constipation, may have a positive effect on kidney function in patients with chronic kidney disease (CKD). The research suggests that the intervention may offer a new approach to treating this condition, which affects millions of people worldwide. The study, which involved 150 patients with moderate CKD, demonstrated that …
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
